These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


197 related items for PubMed ID: 17486898

  • 1. Management of transfusion related risks: is risk communication to non-experts at all possible?
    Hossenlopp C.
    Dev Biol (Basel); 2007; 127():249-58. PubMed ID: 17486898
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Numeracy and the perception and communication of risk.
    Peters E.
    Ann N Y Acad Sci; 2008 Apr; 1128():1-7. PubMed ID: 18469208
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Transfusion risks and limitations.
    Mercuriali F, Inghilleri G.
    Minerva Anestesiol; 1999 May; 65(5):286-92. PubMed ID: 10389406
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Trustworthiness of information about blood donation and transfusion in relation to knowledge and perceptions of risk: an analysis of UK stakeholder groups.
    Ferguson E, Farrell K, James V, Lowe KC.
    Transfus Med; 2004 Jun; 14(3):205-16. PubMed ID: 15180812
    [Abstract] [Full Text] [Related]

  • 15. Risk assessment and cost-effectiveness/utility analysis.
    Busch M, Walderhaug M, Custer B, Allain JP, Reddy R, McDonough B.
    Biologicals; 2009 Apr; 37(2):78-87. PubMed ID: 19243972
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Five drivers shifting the paradigm from product-focused transfusion practice to patient blood management.
    Hofmann A, Farmer S, Shander A.
    Oncologist; 2011 Apr; 16 Suppl 3():3-11. PubMed ID: 21930829
    [Abstract] [Full Text] [Related]

  • 18. Current risks in blood transfusion in Japan.
    Otsubo H, Yamaguchi K.
    Jpn J Infect Dis; 2008 Nov; 61(6):427-33. PubMed ID: 19050347
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE, Kleijnen J.
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.